A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer-Reference-Cited by-同舟云学术

A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer

Published:2012-04-02 Issue:4 Volume:30 Page:309-316
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Dittrich Christian¹,Solska Ewa²,Manikhas Alexey³,Eniu Alexandru⁴,Tjulandin Sergei⁵,Anghel Rodica⁶,Musib Luna⁷,Frimodt-Moller Bente⁷,Liu Yushan⁸,Krejcy Kurt⁹,Láng István¹⁰

Affiliation:

1. 1LBI-ACR VIEnna and ACR-ITR VIEnna/CEADDP, Center for Oncology and Hematology, Kaiser Franz Josef-Spital, Vienna, Austria

2. 2Wojewodzkie Centrum Onkologii W, Gdansk, Poland

3. 3Oncological Dispensary, St. Petersburg, Russia

4. 4Institutul Oncologic I Chiricuta, Cluj, Romania

5. 5Blokhin Cancer Research Center, Moscow, Russia

6. 6Institutul Oncologic Bucharest, Romania

7. 7Eli Lilly and Co, Indianapolis, IN, USA

8. 8i3 Statprobe, Austin, Texas, USA

9. 9Eli Lilly and Company, Regional Operations, Vienna, Austria

10. 10National Institute of Oncology, Budapest, Hungary

Publisher